Total Payments
$58,379
2024 Payments
$679.47
Companies
34
Transactions
281
Medicare Patients
5,144
Medicare Billing
$533,115
Payment Breakdown by Category
Other$38,875 (66.6%)
Travel$13,408 (23.0%)
Food & Beverage$6,082 (10.4%)
Education$13.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,125 | 17 | 58.5% |
| Travel and Lodging | $13,408 | 39 | 23.0% |
| Food and Beverage | $6,082 | 221 | 10.4% |
| Honoraria | $4,750 | 3 | 8.1% |
| Education | $13.89 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $47,923 | 104 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $6,784 | 12 | $0 (2018) |
| Novo Nordisk Inc | $888.15 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $537.90 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $411.62 | 23 | $0 (2024) |
| Lilly USA, LLC | $356.08 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $214.86 | 10 | $0 (2024) |
| Esperion Therapeutics, Inc. | $203.93 | 9 | $0 (2021) |
| Allergan, Inc. | $193.66 | 5 | $0 (2020) |
| Medtronic Vascular, Inc. | $132.26 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $679.47 | 31 | Novo Nordisk Inc ($254.28) |
| 2023 | $576.76 | 33 | Novo Nordisk Inc ($158.97) |
| 2022 | $497.84 | 24 | ABBVIE INC. ($158.68) |
| 2021 | $572.49 | 25 | Novo Nordisk Inc ($202.65) |
| 2020 | $429.55 | 23 | GlaxoSmithKline, LLC. ($96.67) |
| 2019 | $6,969 | 22 | AbbVie, Inc. ($6,649) |
| 2018 | $8,763 | 34 | AbbVie, Inc. ($8,391) |
| 2017 | $39,890 | 89 | AbbVie, Inc. ($32,486) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA | Food and Beverage | In-kind items and services | $53.61 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Cardio-renal | ||||||
| 05/11/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: FOOT AND ANKLE | ||||||
| 04/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $109.56 | General |
| Category: Obesity | ||||||
| 04/11/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Transcatheter Heart Valves | ||||||
| 04/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Respiratory | ||||||
| 03/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,052 | 2,777 | $611,570 | $198,005 |
| 2022 | 17 | 1,475 | 1,950 | $447,952 | $146,037 |
| 2021 | 20 | 911 | 1,592 | $273,707 | $102,260 |
| 2020 | 17 | 706 | 1,251 | $201,367 | $86,813 |
Total Patients
5,144
Total Services
7,570
Medicare Billing
$533,115
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 497 | $152,579 | $43,559 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 236 | 236 | $74,104 | $30,326 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 257 | 481 | $104,377 | $30,239 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 196 | 196 | $76,832 | $22,266 | 29.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 231 | 231 | $45,276 | $17,511 | 38.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 61 | 229 | $29,770 | $9,854 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 65 | $27,625 | $8,234 | 29.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 25 | $10,750 | $5,440 | 50.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $16,960 | $4,823 | 28.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 227 | 227 | $11,350 | $4,263 | 37.6% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 27 | 51 | $12,546 | $4,088 | 32.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 30 | 87 | $14,616 | $3,522 | 24.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $7,904 | $2,606 | 33.0% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 21 | $4,620 | $2,217 | 48.0% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 43 | 43 | $6,278 | $1,881 | 30.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 95 | 95 | $2,375 | $1,784 | 75.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 25 | $1,500 | $911.14 | 60.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 29 | $3,567 | $893.55 | 25.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 27 | $1,215 | $869.13 | 71.5% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 26 | 27 | $1,566 | $810.44 | 51.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 18 | $1,926 | $752.94 | 39.1% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 30 | 30 | $1,200 | $448.65 | 37.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 32 | $1,344 | $340.83 | 25.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 13 | 13 | $1,110 | $324.61 | 29.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 12 | $180.00 | $40.92 | 22.7% |
About Dr. Thomas Hopkins, MD
Dr. Thomas Hopkins, MD is a Internal Medicine healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720045206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Hopkins, MD has received a total of $58,379 in payments from pharmaceutical and medical device companies, with $679.47 received in 2024. These payments were reported across 281 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,125).
As a Medicare-enrolled provider, Hopkins has provided services to 5,144 Medicare beneficiaries, totaling 7,570 services with total Medicare billing of $533,115. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Roseville, CA
- Active Since 04/27/2006
- Last Updated 05/18/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720045206
Products in Payments
- CONTRAVE (Drug) $6,841
- JARDIANCE (Drug) $504.84
- Ozempic (Drug) $473.65
- BREZTRI (Drug) $230.76
- QULIPTA (Drug) $218.95
- TRELEGY ELLIPTA (Drug) $197.73
- MOUNJARO (Drug) $173.55
- Rybelsus (Drug) $155.72
- KYBELLA (Biological) $138.29
- SilverHawk (Device) $132.26
- Wegovy (Drug) $126.63
- NEXLIZET (Drug) $123.50
- FARXIGA (Drug) $114.11
- TRULICITY (Drug) $92.00
- UBRELVY (Drug) $90.63
- NEXLETOL (Drug) $80.43
- EMGALITY (Drug) $76.81
- VRAYLAR (Drug) $73.02
- Aimovig (Biological) $57.17
- LAPIPLASTY SYSTEM (Device) $54.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roseville
Dr. Antonious Attallah, M.d, M.D
Internal Medicine — Payments: $93,114
Internal Medicine $93,114
Shyam Moudgil, Md, MD
Internal Medicine — Payments: $13,535
Internal Medicine $13,535
Dr. Jakkidi Reddy, Md, MD
Internal Medicine — Payments: $13,493
Internal Medicine $13,493
Alexandramary Kelada, Do, Mph, DO, MPH
Internal Medicine — Payments: $12,151
Internal Medicine $12,151
Shawn Aghili, M.d, M.D
Internal Medicine — Payments: $10,130
Internal Medicine $10,130
Cynthia Ro, M.d, M.D
Internal Medicine — Payments: $9,833
Internal Medicine $9,833